Timing of Initial Antibiotic Treatment for Febrile Neutropenia in the Emergency Department: The Need for Evidence-Based Guidelines

Restricted access

Guidelines for the treatment of febrile neutropenia (FN) universally recommend the prompt initiation (<60 minutes) of antibiotic therapy for patients with this complication presenting to medical settings. Unfortunately, administration delays exist in emergency departments where patients with FN frequently seek care. Future guidelines should be based on investigations that clearly indicate the effectiveness of rapid antibiotic therapy. If definitive investigations identify an optimal time period for the initial administration of antibiotics for patients with FN, administrative efforts will be developed to improve the emergency department care of these critically ill patients with cancer.

Correspondence: Demetrios N. Kyriacou, MD, PhD, Northwestern University Feinberg School of Medicine, 211 Ontario Street, Suite 200, Chicago, IL 60611. E-mail: d-kyriacou@northwestern.edu
  • 1.

    BurchenalJ.H.The historical development of cancer chemotherapy. Semin Oncol1977;4:135146.

  • 2.

    PapacRJ. Origins of cancer therapy. Yale J Biol Med2001;74:391398.

  • 3.

    ChabnerBARobertsTG. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer2005;5:6572.

  • 4.

    HirschJ. An anniversary for cancer chemotherapy. JAMA2006;296:15181520.

  • 5.

    FreiELevinRHBodeyGP. The nature and control of infections in patients with acute leukemia. Cancer Res1965;25:15111515.

  • 6.

    BodeyGPBuckleyMSatheYS. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med1966;64:328340.

    • Search Google Scholar
    • Export Citation
  • 7.

    CrawfordJDaleDCKudererNM. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Canc Netw2008;6:109118.

    • Search Google Scholar
    • Export Citation
  • 8.

    RaabSOHoeprichPDWintrobeMM. The clinical significance of fever in acute leukemia. Blood1960;16:16091628.

  • 9.

    TalcottJAFinbergRMayerRJ. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med1988;148:25612568.

    • Search Google Scholar
    • Export Citation
  • 10.

    PizzoPA. Management of fever in patients with cancer and treatment-induced neutropenia. New Engl J Med1993;328:13231332.

  • 11.

    SipsasNVBodeyGPKontoyiannisDP. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer2005;103:11031113.

    • Search Google Scholar
    • Export Citation
  • 12.

    EllisM. Febrile neutropenia. Ann NY Acad Sci2008;1138:329350.

  • 13.

    KrellDJonesAL. Impact of effective prevention and management of febrile neutropenia. Br J Cancer2009;101:S2326.

  • 14.

    LymanGHKudererNMCrawfordJ. Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer2011;117:19171927.

    • Search Google Scholar
    • Export Citation
  • 15.

    KudererNMDaleDCCrawfordJ. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer2006;106:22582266.

    • Search Google Scholar
    • Export Citation
  • 16.

    SchimpffSSatterleeWYoungVM. Empiric therapy with carbenicillin and gentamicin for febrile and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med1971;284:10611065.

    • Search Google Scholar
    • Export Citation
  • 17.

    BodeyGPKetchelSJRodriguezV. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am J Med1979;67:608616.

    • Search Google Scholar
    • Export Citation
  • 18.

    ViscoliC. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrobl Chemother1988;41(Suppl D):6580.

    • Search Google Scholar
    • Export Citation
  • 19.

    BodeyGP. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years. J Antimicrob Chemother2009;63(Suppl 1):i313.

    • Search Google Scholar
    • Export Citation
  • 20.

    de PauwBWilliamsKDe NeeffJ. A prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother1985;28:824828.

    • Search Google Scholar
    • Export Citation
  • 21.

    MorrisonVA. An overview of the management of infection and febrile neutropenia in patients with cancer. Supportive Cancer Ther2005;2:8894.

    • Search Google Scholar
    • Export Citation
  • 22.

    TamCSO’ReillyMAndresenD. Use of empiric antimicrobial therapy in neutropenic fever. Intern Med J2011;41:90101.

  • 23.

    FreifeldAGBowEJSepkowitzKA. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis2011;52:e5693.

    • Search Google Scholar
    • Export Citation
  • 24.

    PrzybyloMAGuleriASharmaR. Febrile neutropenia: national guidelines are urgently needed. BMJ2011;342:244245.

  • 25.

    National Chemotherapy Advisory Group. Chemotherapy services in England: ensuring quality and safety. Available at: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_104501.pdf. Accessed May 12 2012.

    • Search Google Scholar
    • Export Citation
  • 26.

    The Royal College of Radiologists. Clinical Oncology Information Network. Available at: http://www.rcr.ac.uk. Accessed May 12 2012.

  • 27.

    MartiFCullenMHRoilaF. Management of febrile neutropenia: ESMO clinical recommendations. Ann Oncol2009;20(Suppl 4):166169.

  • 28.

    PenackOBuchheidtDChristopeitM. Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology. Ann Oncol2011;22:10191029.

    • Search Google Scholar
    • Export Citation
  • 29.

    FlowersCRSeidenfeldJBowEJ. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol2013;31:794810.

    • Search Google Scholar
    • Export Citation
  • 30.

    BadenLRBensingerWAngaroneM. NCCN Clinical Practice Guidelines in Oncology: Prevention and Treatment of Cancer-Related Infections. Version 2.2014. Available at: NCCN.org. Accessed October 16 2014.

    • Search Google Scholar
    • Export Citation
  • 31.

    VandykADHarrisonMBMacartneyG. Emergency department visits for symptoms experienced by oncology patients: a systematic review. Support Care Cancer2012;20:15891599.

    • Search Google Scholar
    • Export Citation
  • 32.

    PerroneJHollanderJEDatnerEM. Emergency department evaluation of patients with fever and chemotherapy-induced neutropenia. J Emerg Med2004;24:115119.

    • Search Google Scholar
    • Export Citation
  • 33.

    NirenbergAMulhearnLLinS. Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study. Oncol Nurs Forum2004;31:711715.

    • Search Google Scholar
    • Export Citation
  • 34.

    CourtneyDMAldeenAZGormanSM. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist2007;12:10191026.

    • Search Google Scholar
    • Export Citation
  • 35.

    LimCBawdenJWingA. Febrile neutropenia in EDs: the role of an electronic clinical practice guideline. Am J Emerg Med2012:30;511.

  • 36.

    AndreSTabouletPElieC. Febrile neutropenia in French emergency departments: results of a prospective multicentre survey. Crit Care2010;14:R68.

    • Search Google Scholar
    • Export Citation
  • 37.

    SwajcerDCzaykowskiPTurnerD. Assessment and management of febrile neutropenia in emergency departments within a regional health authority: a benchmark analysis. Curr Oncol2011;18:280284.

    • Search Google Scholar
    • Export Citation
  • 38.

    SammutSJMazharD. Management of febrile neutropenia in an acute oncology service. QJM2012;105:327336.

  • 39.

    PerronTEmaraMAhmedS. Time to antibiotics and outcomes in cancer patients with febrile neutropenia. BMC Health Serv Res2014;14:162.

  • 40.

    PinesJM. Timing of antibiotics for acute, severe infections. Emerg Med Clin North Am2008;26:245257.

  • 41.

    KumarARobertsDWoodKE. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med2006:34:15891896.

    • Search Google Scholar
    • Export Citation
  • 42.

    PuskarichMATrzeciakSShapiroNI. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med2011;39:20662071.

    • Search Google Scholar
    • Export Citation
  • 43.

    AroninSIPeduzziPQuagliarelloVJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med1998;129:862869.

    • Search Google Scholar
    • Export Citation
  • 44.

    MinerJRHeegaardWMapesA. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med2001;21:387392.

    • Search Google Scholar
    • Export Citation
  • 45.

    ProulxNFrechetteDToyeB. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM2005;98:291298.

    • Search Google Scholar
    • Export Citation
  • 46.

    StrangJRPughEJ. Meningococcal infections: reducing case fatality by giving penicillin before admission to hospital. Br Med J1992;305:141143.

    • Search Google Scholar
    • Export Citation
  • 47.

    McGarveyRNHarperJJ. Pneumonia mortality reduction and quality improvement in a community hospital. QRB Qual Rev Bull1993;19:124130.

  • 48.

    MeehanTPFineMJKrumholzHM. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA1997;278:20802084.

  • 49.

    HouckPMBratzlerDWNsaW. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med2004;164:637644.

    • Search Google Scholar
    • Export Citation
  • 50.

    HouckPMMacLehoseRFNiedermanMSLoweryJK. Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest2001;119:14201426.

    • Search Google Scholar
    • Export Citation
  • 51.

    GleasonPPMeehanTPFineJM. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med1999;159:25622572.

    • Search Google Scholar
    • Export Citation
  • 52.

    YealyDMAubleTEStoneRA. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med2005;143:881894.

    • Search Google Scholar
    • Export Citation
  • 53.

    NatschSKulbergBJMeisJF. Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department. Arch Intern Med2000;160:13171320.

    • Search Google Scholar
    • Export Citation
  • 54.

    LymanGHRolstonKV. How we treat febrile neutropenia in patients receiving cancer chemotherapy. J Oncol Pract2010;6:149152.

  • 55.

    KollefMH. Broad-spectrum antimicrobials and the treatment of serious bacterial infectious: getting it right up front. Clin Infect Dis2008;47:S313.

    • Search Google Scholar
    • Export Citation
  • 56.

    MicekSTLloydAERitchieDJ. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother2005;49:13061311.

    • Search Google Scholar
    • Export Citation
  • 57.

    VallésJRelloJOchagavíaA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest2003;123:16151624.

    • Search Google Scholar
    • Export Citation
  • 58.

    HarbarthSGarbinoJPuginJ. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med2003;115:529535.

    • Search Google Scholar
    • Export Citation
  • 59.

    LarkinGLWeberJEMoskopJC. Resource utilization in the emergency department: the duty of stewardship. J Emerg Med1998;16:499503.

  • 60.

    American College of Emergency Physicians. Resource utilization in the emergency department: the duty of stewardship. Available at: http://www.acep.org/Clinical---Practice-Management/Resource-Utilization-in-the-Emergency-Department--The-Duty-of-Stewardship/. Accessed March 3 2013.

    • Search Google Scholar
    • Export Citation
  • 61.

    LynnJJChenKFWengYMChiuTF. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department. Hematol Oncol2013;31:189196.

    • Search Google Scholar
    • Export Citation
  • 62.

    FletcherMHodgkissHZhangS. Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer. Pediatr Blood Cancer2013;60:12991306.

    • Search Google Scholar
    • Export Citation
  • 63.

    AnejaRCarcilloJ. Differences between adult and pediatric septic shock. Minerva Anestesiol2011;77:986992.

  • 64.

    BalticTSchlosserEBedellMK. Neutropenic fever: one institution’s quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy. Clin J Oncol Nurs2002;6:337340.

    • Search Google Scholar
    • Export Citation
  • 65.

    CoreyALSnyderS. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital. J Pediatr Oncol Nurs2008;25:208212.

    • Search Google Scholar
    • Export Citation
  • 66.

    BestJTFrithKAndersonF. Implementation of an evidence-based order set to impact initial antibiotic time intervals in adult febrile neutropenia. Oncol Nurs Forum2011;38:661668.

    • Search Google Scholar
    • Export Citation
  • 67.

    AmadoVMVilelaGPQueirozAJrAmaralAC. Effect of a quality improvement intervention to decrease delays in antibiotic delivery in pediatric febrile neutropenia: a pilot study. J Crit Care. 2011;26:103. e9-12.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 167 166 52
PDF Downloads 61 61 14
EPUB Downloads 0 0 0